Literature DB >> 1865418

Rheumatic manifestations in myelodysplastic syndromes.

M Castro1, D L Conn, W P Su, J P Garton.   

Abstract

The myelodysplastic syndromes are characterized by ineffective hematopoiesis with possible transformation to acute nonlymphocytic leukemia. We describe a patient with refractory anemia with excess blasts with unusual rheumatic manifestations of vasculitis, migratory synovitis, arthralgias, and myalgias. A retrospective review over a 6-month period of 162 patients with myelodysplastic syndromes found 16 patients (10%) with several rheumatic manifestations. We divided these manifestations into 4 different categories: cutaneous vasculitis, "lupus-like syndrome," neuropathy, and patients with both a rheumatic disease and a myelodysplastic syndrome. There were 7 with cutaneous vasculitis including leukocytoclastic vasculitis and other individual cases of urticarial vasculitis and panniculitis; 3 with lupus-like manifestations with histological evidence of an inflammatory process; 3 with neuropathic manifestations including peripheral neuropathy, mononeuritis with foot drop, and chronic inflammatory demyelinating polyneuropathy; and 3 patients in which their myelodysplastic syndrome was diagnosed after their rheumatic disease was known, including rheumatoid arthritis. Sjögren's syndrome and mixed connective tissue disease. The class with refractory anemia with excess blasts had 9 patients with rheumatic manifestations but also had the largest number of patients in the study (46/162 or 29%). Three of the 16 patients died, all from the refractory anemia with excess blasts class, reflecting the known mortality in this group of patients. We believe there is a significant association between myelodysplastic syndromes and rheumatic manifestations.

Entities:  

Mesh:

Year:  1991        PMID: 1865418

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  25 in total

Review 1.  Rheumatologic manifestations of benign and malignant haematological disorders.

Authors:  Vinod Ravindran; Parameswaran Anoop
Journal:  Clin Rheumatol       Date:  2011-06-23       Impact factor: 2.980

Review 2.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

3.  A case of erythema nodosum and serositis associated with myelodysplastic syndrome.

Authors:  Jung-Hye Choi; Myung-Ju Ahn; Yong-Wook Park; Ho-Suk Oh; Young-Yeul Lee; In-Soon Kim
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

4.  Sacroiliitis as an initial manifestation of acute myelogenous leukemia.

Authors:  Takumi Hoshino; Takafumi Matsushima; Yasuyuki Saitoh; Arito Yamane; Makiko Takizawa; Hiroyuki Irisawa; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

5.  Myelodysplastic syndrome associated with multiple autoimmune disorders.

Authors:  Dimitrios Farmakis; Evaggelos Polymeropoulos; Aikaterini Polonifi; Spyros Deftereos; Xanthoula Giakoumi; Harris Floudas; Antonia Grapsa; Athanasios Aessopos
Journal:  Clin Rheumatol       Date:  2005-04-13       Impact factor: 2.980

6.  Polychondritis Terminating in Eosinophilic Leukemia.

Authors:  Judit Várkonyi; Lajos Jakab; Attila Zalatnay; Péter Nagy; Rita Vámoss; Tamás Szombathy
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

7.  Successful treatment using tacrolimus plus corticosteroid in a patient with RA associated with MDS.

Authors:  Yuji Nozaki; Yasuaki Nagare; Koji Kinoshita; Fumiaki Urase; Masanori Funauchi
Journal:  Rheumatol Int       Date:  2007-08-29       Impact factor: 2.631

8.  Ankylosing spondylitis in a patient with myelodysplastic syndrome: an association with HLA-B27 or coincidence?

Authors:  Jaejoon Lee; Hyungjin Kim; Joong Kyong Ahn; Ji Won Hwang; Jun Ho Jang; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Rheumatol Int       Date:  2008-10-09       Impact factor: 2.631

Review 9.  Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Authors:  Omar Al Ustwani; Laurie A Ford; Sheila J N Sait; Anne Marie W Block; Maurice Barcos; Carlos E Vigil; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Julian Ambrus; Meir Wetzler
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

10.  Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.

Authors:  Hiroaki Tanaka; Naomi Shimizu; Emi Tougasaki; Chika Kawajiri; Shinichiro Hashimoto; Yusuke Takeda; Shio Sakai; Masahiro Takeuchi; Chikako Ohwada; Emiko Sakaida; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2013-03-22       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.